ABSTRACTThe present invention relates to the use of a therapeutically effective amountof at least onetellurium containing compound having general Formula I:wherein:t, u and v are each 0；each of R1, R8, R9 and R10 is hydrogen；X is chloro； andY is ammonium, the compound being ammonium trichloro(dioxyethylene-O,O')tellurate (AS101),for treating a condition in which inhibition of condition in which inhibitionof interleukin-1.beta.-convertingenzyme is beneficial, the condition being selected from the group consistingof epilepsy, inflammatorybowel disease, Crohn's disease, and ulcerative colitis.
